Liver Function Testing Is Not Helpful for Early Diagnosis of Metastatic Uveal Melanoma

被引:17
|
作者
Mouriaux, Frederic [1 ,2 ,3 ]
Diorio, Caroline [4 ,5 ]
Bergeron, Dan [1 ,2 ]
Berchi, Celia [6 ]
Rousseau, Alain [1 ,2 ]
机构
[1] Hop St Sacrement, CHA, Ctr Univ Ophtalmol, Quebec City, PQ, Canada
[2] Univ Laval, Fac Med, Dept Ophtalmol, Quebec City, PQ G1K 7P4, Canada
[3] CHU Caen, Dept Ophtalmol, F-14000 Caen, France
[4] Hop St Sacrement, CHA, Ctr Rech FRSQ CHA, URESP, Quebec City, PQ, Canada
[5] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ G1K 7P4, Canada
[6] Univ Caen, CHU Caen, INSERM Canc & Populat ERI3, F-14032 Caen, France
关键词
COLLABORATIVE OCULAR MELANOMA; CHOROIDAL MELANOMA; SURVIVAL; DISEASE; COMS; MONOSOMY-3;
D O I
10.1016/j.ophtha.2012.01.045
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Objective: To study the relevance of liver function test (LFT) results for early detection of liver metastasis of uveal melanoma. Design: Evaluation of diagnostic test. Participants: Eighty-eight patients were included in whom metastasis developed while undergoing semiannual follow-up with LFTs, including aspartate-aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyltransferase (gamma GT), lactate dehydrogenase (LDH), and phosphatase alkaline (PA). As controls, 174 patients with uveal melanoma without metastasis were included. Methods: The diagnostic attributes of sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for each test were estimated from cross-tabulation tables of test results according to the diagnosis of metastasis. The proportions of false-positive results between groups of patients with and without metastasis were compared in log-binomial regression models. Main Outcome Measures: Sensitivity, specificity, PPV, NPV, and cost evaluation. Results: Metastases were detected after LFT abnormality (at least 1 abnormal test result) in 40 (45%) patients. The overall sensitivity of LFTs ranged from 12.5% to 58.0%, and the PPV ranged from 9.4% to 38.6%. The overall specificity and NPV were 90% or greater. The proportions of false-positive results between groups of patients with and without metastasis did not differ significantly (all P >= 0.38). Using a cost evaluation, semi-annual screening by LFTs was calculated to cost $35.5/year per patient, including liver imaging induced by true and false-positive results. Conclusions: Isolated or combined LFTs for AST, ALT, gamma GT, LDH, and PA are not helpful for detection of early metastasis. However, the high NPVs suggest that LFT screening can allow clinicians to reassure the patient when the LFT results are negative. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article. Ophthalmology 2012;119:1590-1595 (C) 2012 by the American Academy of Ophthalmology.
引用
收藏
页码:1590 / 1595
页数:6
相关论文
共 50 条
  • [21] Early satellite Metastatic Uveal Melanoma to The Lower Eyelid - The First Report
    Elabjer, Biljana Kuzmanovic
    Miletic, Daliborka
    Busic, Mladen
    Saric, Borna
    Petrovic, Zvonko
    Bradetic, Tatjana
    Bosnar, Damir
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2012, 31 (01): : 27 - 29
  • [22] Prognostic testing of uveal melanoma
    McLean, IW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S185 - S185
  • [23] Efficacy of liver function tests in detecting liver metastasis from uveal melanoma
    Pe'er, JJ
    Kaiserman, I
    Amer, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U249 - U249
  • [24] Therapy of metastatic malignant uveal melanoma
    Jäckel, A
    Bock, M
    Deichmann, M
    Waldmann, V
    Näher, H
    HAUTARZT, 2001, 52 (02): : 98 - 103
  • [25] The genetic evolution of metastatic uveal melanoma
    A. Hunter Shain
    Mette M. Bagger
    Richard Yu
    Darwin Chang
    Shanshan Liu
    Swapna Vemula
    Jingly F. Weier
    Karin Wadt
    Steffen Heegaard
    Boris C. Bastian
    Jens F. Kiilgaard
    Nature Genetics, 2019, 51 : 1123 - 1130
  • [26] Transhepatic Therapies for Metastatic Uveal Melanoma
    Eschelman, David J.
    Gonsalves, Carin F.
    Sato, Takami
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2013, 30 (01) : 39 - 48
  • [27] Effectiveness of Treatments for Metastatic Uveal Melanoma
    Augsburger, James J.
    Correa, Zelia M.
    Shaikh, Adeel H.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (01) : 119 - 127
  • [28] Variates of survival in metastatic uveal melanoma
    Rietschel, P
    Panageas, KS
    Hanlon, C
    Patel, A
    Abramson, DH
    Chapman, PB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8076 - 8080
  • [29] The genetic evolution of metastatic uveal melanoma
    Shain, A. Hunter
    Bagger, Mette M.
    Yu, Richard
    Chang, Darwin
    Liu, Shanshan
    Vemula, Swapna
    Weier, Jingly F.
    Wadt, Karin
    Heegaard, Steffen
    Bastian, Boris C.
    Kiilgaard, Jens F.
    NATURE GENETICS, 2019, 51 (07) : 1123 - +
  • [30] Metastatic patterns in posterior uveal melanoma
    Hindso, Tine Gadegaard Gadegaard
    Madsen, Karine
    Bjerrum, Camilla Wium
    Faber, Carsten
    Nissen, Kristoffer
    Heegaard, Steffen
    Bagger, Mette
    Kiilgaard, Jens F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)